Skip Navigation


Carcinogenesis Advance Access originally published online on August 12, 2004
Carcinogenesis 2004 25(12):2385-2395; doi:10.1093/carcin/bgh248
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
25/12/2385    most recent
bgh248v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lan, M.
Right arrow Articles by Sawada, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lan, M.
Right arrow Articles by Sawada, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis vol.25 no.12 © Oxford University Press 2004; all rights reserved.

ARTICLE

Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line

Mengdong Lan, Takashi Kojima1, Makoto Osanai, Hideki Chiba and Norimasa Sawada

Department of Pathology, Sapporo Medical University School of Medicine, S1 W17, Sapporo 060-8556, Japan

1 To whom correspondence should be addressed. Tel: +81 11 611 2111; Fax: +81 11 613 5665; Email: ktakashi{at}sapmed.ac.jp

The epithelial to mesenchymal transition (EMT) is considered to be an important event during malignant tumor progression and metastasis. Although Raf/MEK/ERK signaling causes EMT, the mechanisms, including the signaling pathways, are as yet unclear. In the present study we have examined the effects of signal transduction pathways on oncogenic Raf-1-induced EMT, using an immortalized mouse hepatic cell line. Oncogenic Raf-1-induced EMT is characterized by down-regulation of adherens and tight junctions and the reorganization of actin. An active Raf-1 gene was introduced into a mouse hepatic cell line which was then treated with the MAP kinase inhibitor PD98059, the p38 MAP kinase inhibitor SB203580, the PI3 kinase inhibitor LY294002 or the c-Src tyrosine kinase inhibitor PP2. The expression and localization of the adherens and tight junction proteins E-cadherin, occludin, ZO-1, claudin-1 and claudin-2 were determined by western blotting, RT–PCR and immunocytochemistry. The barrier function of tight junctions was assessed by measurements of transepithelial electric resistance (TER) and permeability in terms of fluxes of [14C]mannitol and [14C]inulin. In Raf-1-transfected cells expression of occludin and claudin-2 was markedly down-regulated at the protein and mRNA levels and the TER value was decreased, while the permeability was increased. The distribution of ZO-1, pancadherin and F-actin was changed from linear to zipper-like structures at cell borders. In Raf-1-transfected cells treated with PD98059 and SB203580, but not LY294002, expression and localization of claudin-2, but not occludin, recovered, together with barrier function, measured as the TER value. The distributions of ZO-1, pancadherin and F-actin also recovered on treatment with PD98059 and SB203580, but not LY294002. Expression and localization of occludin recovered slightly on treatment with PP2. Thus, oncogenic Raf-1 regulates EMT via distinct MAP kinase, p38 MAP kinase and c-Src tyrosine kinase signal pathways in the mouse hepatic cell line.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
R. Yanai, J.-A. Ko, N. Nomi, N. Morishige, T.-i. Chikama, A. Hattori, K. Hozumi, M. Nomizu, and T. Nishida
Upregulation of ZO-1 in Cultured Human Corneal Epithelial Cells by a Peptide (PHSRN) Corresponding to the Second Cell-Binding Site of Fibronectin
Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2757 - 2764.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
V. Pollack, R. Sarkozi, Z. Banki, E. Feifel, S. Wehn, G. Gstraunthaler, H. Stoiber, G. Mayer, R. Montesano, F. Strutz, et al.
Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1714 - F1726.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Y. Tokunaga, T. Kojima, M. Osanai, M. Murata, H. Chiba, H. Tobioka, and N. Sawada
A Novel Monoclonal Antibody Against the Second Extracellular Loop of Occludin Disrupts Epithelial Cell Polarity
J. Histochem. Cytochem., July 1, 2007; 55(7): 735 - 744.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Guillemot and S. Citi
Cingulin Regulates Claudin-2 Expression and Cell Proliferation through the Small GTPase RhoA
Mol. Biol. Cell, August 1, 2006; 17(8): 3569 - 3577.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Shimada, M. Nakamura, S. Matsuyoshi, E. Ishida, and N. Konishi
Specific positive and negative effects of FLIP on cell survival in human prostate cancer
Carcinogenesis, July 1, 2006; 27(7): 1349 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. B. N. Lee, E. Huang, and H. J. Ward
Tight junction biology and kidney dysfunction
Am J Physiol Renal Physiol, January 1, 2006; 290(1): F20 - F34.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.